Rapid-Deployment Aortic Valve Replacement: Clear Benefits Without a Clear Target Patient Population.

Semin Thorac Cardiovasc Surg

Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

Published: June 2018

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semtcvs.2018.02.021DOI Listing

Publication Analysis

Top Keywords

rapid-deployment aortic
4
aortic valve
4
valve replacement
4
replacement clear
4
clear benefits
4
benefits clear
4
clear target
4
target patient
4
patient population
4
clear
2

Similar Publications

Background:  The long-term outcomes of combined rapid-deployment aortic valve replacement (RDAVR) with coronary artery bypass graft surgery (CABG) are not well explored. We report 3-year results from the INCA registry on combined RDAVR with CABG.

Methods:  INCA is a prospective, multicenter registry that enrolled 224 patients undergoing RDAVR with CABG at 10 cardiac institutions in Germany.

View Article and Find Full Text PDF

Pathology-Independent Expansion of Indications for Rapid-Deployment Aortic Valve Replacement: Midterm Outcomes.

Thorac Cardiovasc Surg

January 2025

Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Background:  This study evaluated the midterm outcomes of rapid deployment aortic valve replacement (RDAVR) performed regardless of pathology for various aortic valve diseases at a single center.

Methods:  Of the 344 patients who underwent RDAVR using Edwards INTUITY during the study period at our institution, 176 had bicuspid valve diseases (51.2%), 20 had pure aortic regurgitation (5.

View Article and Find Full Text PDF

The need for a permanent pacemaker (PPM) implantation after surgical aortic valve implantation (SAVR) is a recognized postoperative complication, with potentially long-term reduced survival. From 1987 to 2017, 2500 consecutive patients underwent SAVR with a biological valve with or without concomitant procedures such as CABG or mitral valve repair. Mechanical valves or valves in another position were excluded.

View Article and Find Full Text PDF

Background: There are several high-risk treatment options for valve failure of a biological full root replacement. When tailoring the best treatment option for the patient, implantation of a rapid deployment valve (RDV) should be considered.

Case Presentation: Six patients presented with aortic regurgitation in a full root Freestyle bioprosthesis.

View Article and Find Full Text PDF
Article Synopsis
  • * The use of this approach significantly increased from 18.7% in 2019 to 97.8% by 2023, with a mean procedure time of 127 minutes and no intraoperative deaths reported.
  • * Thirty-day adverse events included a 1.9% rate of major complications, with factors like intraoperative conversion and respiratory failure being linked to higher risks of complications and mortality.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!